181 results
8-K
EX-4.2
CRVO
CervoMed Inc
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
of the effect with respect to the trial’s primary endpoint and each of its secondary endpoints, and any material safety data, in each case, derived from
8-K/A
EX-99.3
8rz 9tl9cu3ii
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.2
grhf4c0 hi2bh
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
j3ktdm89i4ni
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-3.5
h8morglkd29tmyk
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
425
EX-99.1
2usbtpwky
14 Aug 23
Business combination disclosure
4:16pm
8-K
EX-99.1
cvy18m gl4u9jk8x9xa
14 Aug 23
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
4:15pm
424B3
0xxz71ob99hp
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
fbjc0t78
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
CORRESP
956otf yupl
22 Jun 23
Correspondence with SEC
12:00am
UPLOAD
dm2qi
9 Jun 23
Letter from SEC
12:00am
S-4
v6mcgdc7hg pmx
10 May 23
Registration of securities issued in business combination transactions
9:56pm